Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era-Reference-Cited by-同舟云学术

Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era

Published:2023-04-07 Issue:13 Volume:29 Page:2015-2033
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:World J Gastroenterol

Author:

Brzdęk Michał,Zarębska-Michaluk Dorota,Rzymski Piotr,Lorenc Beata,Kazek Adam,Tudrujek-Zdunek Magdalena,Janocha-Litwin Justyna,Mazur Włodzimierz,Dybowska Dorota,Berak Hanna,Parfieniuk-Kowerda Anna,Klapaczyński Jakub,Sitko Marek,Sobala-Szczygieł Barbara,Piekarska Anna,Flisiak Robert

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference53 articles.

1. World Health Organization. Hepatitis C. [cited 15 November 2022]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

2. Natural history of hepatitis C

3. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

4. Side effects of therapy of hepatitis C and their management

5. Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study;Cureus;2024-08-30

2. Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection;Viruses;2024-08-30

3. Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment;Journal of Viral Hepatitis;2024-08-07

4. Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example;Infectious Diseases and Therapy;2024-03

5. Hepatitis B virus coinfection in patients treated for chronic hepatitis C: Clinical characteristics, risk of reactivation with long-term follow-up and effectiveness of antiviral therapy;Polish Archives of Internal Medicine;2024-01-02